Latest filing published 13 Jun 2024 for Pacira BioSciences, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Charles A. Reinhart III: trading record in brief
All filings by Charles A. Reinhart III on record concern Pacira BioSciences, Inc., in the capacity of finance chief. Between 14 June 2017 and 12 June 2024, the trades on record add up to 16 filings.
No open-market purchase appears, only 7 sales worth €494k. The rest of the record consists of 9 share grants.
Most recently, on 13 June 2024, the filings show a share grant in Pacira BioSciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Charles A. Reinhart III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,220 shares0Common StockSEC:0001396814-24-000081:0
- 2,979 shares@ US$30.8915.6% of flowCommon StockSEC:0001396814-24-000054:0
- 9,000 shares0Common StockSEC:0001209191-23-038028:0
- 1,236 shares@ US$38.9918.3% of flowCommon StockSEC:0001209191-23-035261:0
- 2,516 shares@ US$61.3740.014% mcap35.2% of flowCommon StockSEC:0001209191-22-035230:0
- 6,000 shares0Common StockSEC:0001209191-21-040093:0
- 2,648 shares@ US$61.03732.7% of flowCommon StockSEC:0001209191-21-038891:0
7 of 7 declarations
